Wolfram Samlowski, M.D.
Head of the Section of Melanoma, Renal Cancer and Immunotherapy
Dr. Samlowski received his B.A. and M.D. from Ohio State University. He completed a residency in internal medicine at Wayne State University in 1980 and a clinical fellowship in hematology/oncology at the University of Utah School of Medicine in 1984. He is Board Certified in Internal Medicine and Oncology. Formerly, Dr. Samlowski was a member of the faculty at the Huntsman Cancer Institute, Salt Lake City from 1984 to 2007, rising to the rank of professor in the Division of Oncology. He is an active member of the Melanoma and Genitourinary Cancer Committees of the Southwest Oncology Group. Dr. Samlowski has served as a member of the National Comprehensive Cancer Network Practice Guidelines Committee for melanoma and renal carcinoma for many years.
Dr. Samlowski specializes in the treatment of melanoma and kidney cancer with emphasis on treatments that activate the immune system to fight these cancers. He is also involved in translational research—the development of new ideas and treatments derived from laboratory experiments into actual cancer treatments for patients. A key concept is that current melanoma and renal cancer treatments can cure only a small percentage of patients with advanced disease. Dr. Samlowski is very active in identifying active new agents and obtaining these for clinical testing at the NVCI. These clinical trials provide hope for patients when standard treatments have not proven useful.
Samlowski Lab
